Clinical Trial Update: Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating conservative iron chelation as a disease-modifying strategy in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University Hospital, Lille | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED